Nucleoside-modified mRNA encoding HSV-2 glycoproteins C, D, and E prevents clinical and subclinical genital herpes
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nucleoside-modified mRNA encoding HSV-2 glycoproteins C, D, and E prevents clinical and subclinical genital herpes
Authors
Keywords
-
Journal
Science Immunology
Volume 4, Issue 39, Pages eaaw7083
Publisher
American Association for the Advancement of Science (AAAS)
Online
2019-09-21
DOI
10.1126/sciimmunol.aaw7083
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Slow Delivery Immunization Enhances HIV Neutralizing Antibody and Germinal Center Responses via Modulation of Immunodominance
- (2019) Kimberly M. Cirelli et al. CELL
- Surface plasmon resonance (SPR) reveals direct binding of HSV glycoproteins gH/gL to gD and locates a gH/gL binding site on gD
- (2019) Tina M. Cairns et al. JOURNAL OF VIROLOGY
- Antibody responses to crucial functional epitopes as a novel approach to assess immunogenicity of vaccine adjuvants
- (2019) Sita Awasthi et al. VACCINE
- Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses
- (2018) Norbert Pardi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- mRNA vaccines — a new era in vaccinology
- (2018) Norbert Pardi et al. NATURE REVIEWS DRUG DISCOVERY
- Vaccine-induced antibodies to herpes simplex virus glycoprotein D epitopes involved in virus entry and cell-to-cell spread correlate with protection against genital disease in guinea pigs
- (2018) Lauren M. Hook et al. PLoS Pathogens
- Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies
- (2018) Norbert Pardi et al. Nature Communications
- Antiviral Approaches for the Treatment of Herpes Simplex Virus Infections in Newborn Infants
- (2018) Claudette L. Poole et al. Annual Review of Virology
- A trivalent gC2/gD2/gE2 vaccine for herpes simplex virus generates antibody responses that block immune evasion domains on gC2 better than natural infection
- (2018) Lauren M. Hook et al. VACCINE
- The HSV-1 live attenuated VC2 vaccine provides protection against HSV-2 genital infection in the guinea pig model of genital herpes
- (2018) David I. Bernstein et al. VACCINE
- Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination
- (2017) Norbert Pardi et al. NATURE
- A trivalent subunit antigen glycoprotein vaccine as immunotherapy for genital herpes in the guinea pig genital infection model
- (2017) Sita Awasthi et al. Human Vaccines & Immunotherapeutics
- Global sensing of the antigenic structure of herpes simplex virus gD using high-throughput array-based SPR imaging
- (2017) Tina M. Cairns et al. PLoS Pathogens
- An HSV-2 Trivalent Vaccine Is Immunogenic in Rhesus Macaques and Highly Efficacious in Guinea Pigs
- (2017) Sita Awasthi et al. PLoS Pathogens
- First estimates of the global and regional incidence of neonatal herpes infection
- (2017) Katharine J Looker et al. Lancet Global Health
- Materials for non-viral intracellular delivery of messenger RNA therapeutics
- (2016) Kevin J. Kauffman et al. JOURNAL OF CONTROLLED RELEASE
- Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes
- (2015) Norbert Pardi et al. JOURNAL OF CONTROLLED RELEASE
- Antibodies Are Required for Complete Vaccine-Induced Protection against Herpes Simplex Virus 2
- (2015) William P. Halford et al. PLoS One
- Lipid-based mRNA vaccine delivery systems
- (2014) Patrick Midoux et al. Expert Review of Vaccines
- T Follicular Helper Cell Differentiation, Function, and Roles in Disease
- (2014) Shane Crotty IMMUNITY
- Blocking Herpes Simplex Virus 2 Glycoprotein E Immune Evasion as an Approach To Enhance Efficacy of a Trivalent Subunit Antigen Vaccine for Genital Herpes
- (2014) S. Awasthi et al. JOURNAL OF VIROLOGY
- Correlate of Immune Protection Against HSV-1 Genital Disease in Vaccinated Women
- (2013) R. B. Belshe et al. JOURNAL OF INFECTIOUS DISEASES
- Protection Provided by a Herpes Simplex Virus 2 (HSV-2) Glycoprotein C and D Subunit Antigen Vaccine against Genital HSV-2 Infection in HSV-1-Seropositive Guinea Pigs
- (2013) S. Awasthi et al. JOURNAL OF VIROLOGY
- Germinal Centers
- (2012) Gabriel D. Victora et al. Annual Review of Immunology
- Properties of mouse and human IgG receptors and their contribution to disease models
- (2012) P. Bruhns BLOOD
- Efficacy Results of a Trial of a Herpes Simplex Vaccine
- (2012) Robert B. Belshe et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunogenicity and Efficacy of Intramuscular Replication-Defective and Subunit Vaccines against Herpes Simplex Virus Type 2 in the Mouse Genital Model
- (2012) Simon Delagrave et al. PLoS One
- Herpes Virus Fusion and Entry: A Story with Many Characters
- (2012) Roselyn J. Eisenberg et al. Viruses-Basel
- Immunization with a Vaccine Combining Herpes Simplex Virus 2 (HSV-2) Glycoprotein C (gC) and gD Subunits Improves the Protection of Dorsal Root Ganglia in Mice and Reduces the Frequency of Recurrent Vaginal Shedding of HSV-2 DNA in Guinea Pigs Compared to Immunization with gD Alone
- (2011) S. Awasthi et al. JOURNAL OF VIROLOGY
- An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection
- (2008) Katharine Looker BULLETIN OF THE WORLD HEALTH ORGANIZATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More